Home Cart 0 Sign in  

[ CAS No. 28188-41-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 28188-41-2
Chemical Structure| 28188-41-2
Structure of 28188-41-2 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 28188-41-2 ]

Related Doc. of [ 28188-41-2 ]

Alternatived Products of [ 28188-41-2 ]

Product Details of [ 28188-41-2 ]

CAS No. :28188-41-2 MDL No. :MFCD00001809
Formula : C8H6BrN Boiling Point : -
Linear Structure Formula :- InChI Key :CVKOOKPNCVYHNY-UHFFFAOYSA-N
M.W : 196.04 Pubchem ID :97249
Synonyms :

Calculated chemistry of [ 28188-41-2 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.12
Num. rotatable bonds : 1
Num. H-bond acceptors : 1.0
Num. H-bond donors : 0.0
Molar Refractivity : 43.99
TPSA : 23.79 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -9.85 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.01
Log Po/w (XLOGP3) : -3.31
Log Po/w (WLOGP) : 2.3
Log Po/w (MLOGP) : 2.25
Log Po/w (SILICOS-IT) : 2.81
Consensus Log Po/w : 1.21

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 3.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : 0.65
Solubility : 879.0 mg/ml ; 4.49 mol/l
Class : Highly soluble
Log S (Ali) : 3.38
Solubility : 475000.0 mg/ml ; 2420.0 mol/l
Class : Highly soluble
Log S (SILICOS-IT) : -3.74
Solubility : 0.0353 mg/ml ; 0.00018 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.95

Safety of [ 28188-41-2 ]

Signal Word:Danger Class:8
Precautionary Statements:P301+P330+P331-P303+P361+P353-P363-P304+P340-P310-P321-P260-P264-P280-P305+P351+P338-P405-P501 UN#:3261
Hazard Statements:H314 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 28188-41-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 28188-41-2 ]
  • Downstream synthetic route of [ 28188-41-2 ]

[ 28188-41-2 ] Synthesis Path-Upstream   1~17

  • 1
  • [ 28188-41-2 ]
  • [ 64407-07-4 ]
Reference: [1] Organic Letters, 2008, vol. 10, # 6, p. 1107 - 1110
  • 2
  • [ 874-97-5 ]
  • [ 28188-41-2 ]
Reference: [1] Organic Process Research and Development, 2002, vol. 6, # 2, p. 190 - 191
  • 3
  • [ 10406-24-3 ]
  • [ 28188-41-2 ]
Reference: [1] Patent: US6187945, 2001, B1,
  • 4
  • [ 620-22-4 ]
  • [ 28188-41-2 ]
Reference: [1] Collection of Czechoslovak Chemical Communications, 2010, vol. 75, # 10, p. 1041 - 1050
[2] Journal of Organic Chemistry, 1990, vol. 55, # 3, p. 1040 - 1043
[3] Journal of Organic Chemistry, 1952, vol. 17, p. 272,284
[4] Justus Liebigs Annalen der Chemie, 1925, vol. 445, p. 232
[5] Atti della Accademia Nazionale dei Lincei, Classe di Scienze Fisiche, Matematiche e Naturali, Rendiconti, 1925, vol. <6> 2, p. 426
[6] Die Pharmazie, 1973, vol. 28, # 11, p. 724 - 729
[7] Archiv der Pharmazie, 1978, vol. 311, # 2, p. 81 - 97
[8] Journal of the Chemical Society, Dalton Transactions: Inorganic Chemistry (1972-1999), 1990, # 1, p. 257 - 261
[9] Journal of Organic Chemistry, 1990, vol. 55, # 3, p. 1040 - 1043
[10] Journal of the Indian Chemical Society, 1990, vol. 67, # 11, p. 909 - 911
[11] Journal of Fluorine Chemistry, 1996, vol. 77, # 1, p. 65 - 70
[12] Journal of Physical Organic Chemistry, 2000, vol. 13, # 10, p. 587 - 590
[13] Pest Management Science, 2000, vol. 56, # 10, p. 875 - 881
[14] Organic Letters, 2013, vol. 15, # 16, p. 4194 - 4197
  • 5
  • [ 64407-07-4 ]
  • [ 28188-41-2 ]
Reference: [1] Atti della Accademia Nazionale dei Lincei, Classe di Scienze Fisiche, Matematiche e Naturali, Rendiconti, 1925, vol. <6> 2, p. 426
  • 6
  • [ 7726-95-6 ]
  • [ 620-22-4 ]
  • [ 28188-41-2 ]
Reference: [1] Atti della Accademia Nazionale dei Lincei, Classe di Scienze Fisiche, Matematiche e Naturali, Rendiconti, 1925, vol. <6> 2, p. 426
  • 7
  • [ 28188-41-2 ]
  • [ 10406-24-3 ]
Reference: [1] Chemical Communications, 2015, vol. 51, # 39, p. 8253 - 8256
[2] Bioorganic and Medicinal Chemistry Letters, 2003, vol. 13, # 20, p. 3477 - 3482
[3] Journal of the American Chemical Society, 1991, vol. 113, # 11, p. 4208 - 4218
[4] Journal of Medicinal Chemistry, 2015, vol. 58, # 3, p. 1067 - 1088
[5] Patent: WO2016/7966, 2016, A2,
  • 8
  • [ 201230-82-2 ]
  • [ 28188-41-2 ]
  • [ 2084-13-1 ]
Reference: [1] Tetrahedron Letters, 1983, vol. 24, # 37, p. 4005 - 4008
  • 9
  • [ 544-97-8 ]
  • [ 28188-41-2 ]
  • [ 34136-57-7 ]
  • [ 620-22-4 ]
Reference: [1] Journal of Organic Chemistry, 1993, vol. 58, # 24, p. 6908 - 6910
  • 10
  • [ 28188-41-2 ]
  • [ 52010-98-7 ]
Reference: [1] Journal of Medicinal Chemistry, 1981, vol. 24, # 5, p. 535 - 544
  • 11
  • [ 74-89-5 ]
  • [ 28188-41-2 ]
  • [ 90389-96-1 ]
YieldReaction ConditionsOperation in experiment
100% at 20℃; for 3 h; Inert atmosphere Step 1: 3-[(methylamino)methyllbenzonitrileIn a 3 necked round bottom flask (250 ml), put under nitrogen atmosphere, a solution of 3- (bromomethyl)benzonitrile (5 g; 25.5 mmol; 1 eq.) in anhydrous THF (20 ml) was added dropwise into methylamine (63.76 ml; 2 M; 127.52 mmol; 5 eq.) (2M solution in THF) over 1 hour. The reaction mixture was stirred at RT for 2 hours. Some bis-benzylation was observed (7percent). The reaction mixture was filtered to remove the salt. The filtrate was evaporated under reduced pressure. The residue was taken up with DCM and evaporated again to give the title compound as a yelllow oil (3.78 g, quantitative yield). It was used in the next step without any further purification. LC/MS (Method B) 146.8 (M+H)+.
96% at 20℃; for 24 h; To a commercially available solution of methylamine 2M in tetrahydrofuran (200 ml, 400 mmol), 11.2 g (57.1 mmol) of 3-(bromomethyl)benzonitrile dissolved in 112 ml of <n="46"/>tetrahydrofuran were added dropwise. The reaction mixture was stirred at room temperature for 24 hours. The solvent was removed under reduced pressure. The obtained residue was diluted with ethyl ether and extracted with 1 N HCI. The acidic extracts were basified with solid potassium carbonate and the basic solution extracted with dichloromethane. The organic phase was dried (MgSO4) and concentrated under reduced pressure. The title compound was obtained as an oil (7.98g, 96percent).
82% at 0 - 20℃; for 3.16 h; To a stirred solution of methylamine(40percent in water) (200 ml_) under N2, was added 3-(bromomethyl)benzonitrile (10 g, 0.051 mol) slowly in small portions over a period of 10min at O0C. After being stirred at RT for 3h, the reaction mixture was extracted with DCM. Then the organic layer was washed with brine and dried over sodium sulphate and concentrated under reduced pressure. The obtainted crude was purified using column chromatography on silica gel (pet ether/ehyl acetate) to afford the title compound as a pale yellow liquid (6.1 g, 82percent). 1H NMR (DMSO-de, 400 MHz) δ 7.74 (s, 1 H), 7.63-7.68 (m, 2H), 7.48-7.52 (m, 1 H), 3.66 (s, 2H), 2.22 (s, 3H).
82% at 0 - 20℃; for 3.16667 h; To a stirred solution of methylamine (40percent in water, 200 mL) under N2, was added 3- (bromomethyl)benzonitrile (10 g, 51 mmol) slowly in portions over 10 minutes at O0C. After being stirred at RT for 3 hours, the reaction mixture was extracted with DCM. Then the organic layer was washed with brine and dried over sodium sulphate and concentrated under reduced pressure. The residue was purified by chromatography (silica, pet ether/EtOAc) to afford the title compound as a pale yellow liquid (6.1 g, 82percent). 1H NMR (DMSOd6, 400 MHz) δ 7.74 (s, 1 H), 7.63-7.68 (m, 2H), 7.48-7.52 (m, 1 H), 3.66 (s, 2H), 2.22 (s, 3H).

Reference: [1] Patent: WO2012/4287, 2012, A1, . Location in patent: Page/Page column 93-94
[2] Patent: WO2007/124898, 2007, A1, . Location in patent: Page/Page column 44-45
[3] Patent: WO2009/43889, 2009, A2, . Location in patent: Page/Page column 166
[4] Patent: WO2010/112461, 2010, A1, . Location in patent: Page/Page column 67
[5] Chemische Berichte, 1937, vol. 70, p. 1241,1249
[6] Journal of Medicinal Chemistry, 1986, vol. 29, # 1, p. 40 - 44
[7] Patent: WO2005/5395, 2005, A2, . Location in patent: Page 80-81
  • 12
  • [ 28188-41-2 ]
  • [ 82072-23-9 ]
YieldReaction ConditionsOperation in experiment
100%
Stage #1: With diisobutylaluminium hydride In tetrahydrofuran; toluene at 0℃; for 2.5 h;
Stage #2: With hydrogenchloride; water In tetrahydrofuran; dichloromethane; toluene for 1 h;
Synthesis of Compounds 60 and 61
Compounds 60 and 61 were synthesized from α-bromomethyl-tolunitril.
To a solution of α-bromomethyl-tolunitril (15.3 mmol) in toluene (30 mL) was added DIBAL-H in THF (1.0 M, 1.4 eq.) at 0° C. within 30 minutes.
After stirring at 0° C. for 2 h, the reaction mixture was poured into a mixture of 40 mL of methylene chloride and 100 mL of 10percent HCl.
The resulting mixture was stirred for 1 h and the organic layer was washed with water and then brine, and the aqueous was extracted with methylene chloride twice.
After dried over Na2SO4, filtered, and concentrated, the obtained semi-oily product was stored in a refrigerator to give 3-(bromomethyl)benzaldehyde as a white crystalline solid in quantitative yield.
Reaction of the resulting compound with acetone in ethanol following the procedure descripted in Scheme 4 yielded Compound 61 as a light yellow crystalline solid. ESI MS m/z: 420.9 [M+H]+; 1H NMR (400 MHz, CDCl3) δ: 7.71 (d, 2H, J=16.0 Hz, H-1, 5), 7.63-7.60 (m, 2H, aromatic ring H), 7.54-7.50 (m, 2H, aromatic ring H), 7.44-7.37 (m, 4H, aromatic ring H), 7.08 (d, 2H, J=16.0 Hz, H-2, 4), 4.50 (s, 4H, -CH2Br).
93% With diisobutylaluminium hydride In tetrahydrofuran; toluene at 0℃; for 2 h; To a solution of 3-(bromomethyl)benzonitrile (212mg, 1.081 mmol) in 2.5mL Toluene was added dropwise 1M DIBAL-H in THF (1.5 ml, 1.5 mmol) at 0° C. After stirring at 0°C for 2 h the reaction was diluted with DCM and IN aq. HCl and stirred for 1 hour. The organic layer was washed with brine, dried over sodium sulfate, and concentrated yielding the titled compound as an orange oil. (200mg, 0.970 mmol, 93percent yield)
88% With diisobutylaluminium hydride In toluene at -78 - 0℃; for 1.5 h; 3- (Bromomethyl) benzonitrile (1.0 g, 5.10 mmol) was dissolved in toluene (17 L), cooled to 0 C and 1.5 M DIBAL (4.08 L, 6.12 mmol) dissolved in toluene was slowly added dropwise. The reaction solution was stirred at 0 ° C for 1.5 hours, and 1N HCl solution was slowly added thereto.The reaction solution was diluted with CH2Cl2 and washed with water. The organic solvent was dried over anhydrous MgSO4, filtered and concentrated under reduced pressure. The resulting residue was purified by silica gel chromatography (n-Hex / EtOAc = 9/1) to obtain the target compound 3- (bromomethyl) benzaldehyde (880 mg, 88percent).
71%
Stage #1: With diisobutylaluminium hydride In chloroform; chlorobenzene at 5℃; for 1 h; Cooling with ice
Stage #2: With hydrogenchloride; water In hexane; chloroform; chlorobenzene
Step 1:
3-Bromomethyl-benzaldehyde
A solution of 3-cyanobenzyl bromide (available from Aldrich; 10.1 g, 51.5 mmol) in chlorobenzene (100 mL) was cooled in an ice-water bath.
A solution of diisobutylaluminum hydride in hexanes (available from Aldrich; 1 M; 65 mL, 65 mmol) was added over 25 minutes, and the reaction mixture was stirred below 5° C. for 1 h.
Chloroform (100 mL) was added, followed by 10percent aqueous hydrochloric acid (dropwise).
The layers were separated and the organic layer was washed with water.
Each aqueous layer was back extracted with chloroform, and the organic phases were combined, dried over sodium sulfate, filtered, evaporated and purified by chromatography, eluting with 0-40percent ethyl acetate/hexanes to give pure fractions and a number of impure fractions.
The impure fractions were chromatographed a second time, eluting with 0-27percent ethyl acetate/hexanes.
Fractions homogeneous for the product from the two chromatographic separations were combined and concentrated.
The residue was dissolved in ether and layered with hexane.
The mixture was chilled overnight and the solid was filtered off, washed with hexane and dried under high vacuum at room temperature to give 3-bromomethyl-benzaldehyde (7.32 g, 71percent).

Reference: [1] Patent: US2012/46247, 2012, A1, . Location in patent: Page/Page column 29
[2] Chemical Communications, 2014, vol. 50, # 56, p. 7424 - 7426
[3] Patent: WO2017/223086, 2017, A1, . Location in patent: Page/Page column 84
[4] Tetrahedron, 1997, vol. 53, # 20, p. 6755 - 6790
[5] Patent: KR2018/56603, 2018, A, . Location in patent: Paragraph 0363; 0365-0367
[6] Journal of the American Chemical Society, 1992, vol. 114, # 12, p. 4889 - 4898
[7] Journal of the American Chemical Society, 1991, vol. 113, # 11, p. 4208 - 4218
[8] Organic and Biomolecular Chemistry, 2010, vol. 8, # 5, p. 1181 - 1187
[9] Journal of the American Chemical Society, 1997, vol. 119, # 33, p. 7726 - 7733
[10] Patent: US2011/124686, 2011, A1, . Location in patent: Page/Page column 25
[11] Archiv der Pharmazie, 1997, vol. 330, # 8, p. 247 - 252
[12] Dalton Transactions, 2012, vol. 41, # 23, p. 7092 - 7097
  • 13
  • [ 7647-01-0 ]
  • [ 28188-41-2 ]
  • [ 82072-23-9 ]
YieldReaction ConditionsOperation in experiment
77% With dibal-H In toluene Compound 8
A 2 L round-bottom was charged with 3-(bromomethyl)-benzonitrile 7 (48.0 g) and dry toluene (480 mL).
After cooling to 0° C., DIBAL-H (1.0 M in PhMe, 306 mL) was added over a 90 min period via pressure-equalizing addition funnel under N2.
Once addition was complete, the reaction was allowed to stir an additional 90 min.
Then 1.0 M aq HCl (1.2 L) was added carefully, and the reaction was allowed to stir for 15 min.
The organic phase was collected, and the aq phase was extracted (2*250 mL Et2O).
All organic extracts were combined, dried (MgSO4), filtered, and concentrated.
The oily residue was purified on a 330 g normal phase silica gel column (combiflash, EtOAc/Hex 10:90 to 50:50, gradient), giving the 3-(bromomethyl)-benzaldehyde (37.14 g, 77percent yield).
1H-NMR (300 MHz, CDCl3) d: 9.98 (s, 1H), 7.86 (app. s, 1H), 7.77 (app.d, J=7.6 Hz, 1H), 7.63 (app. d, J=7.7 Hz, 1H), 7.48 (app. dd, J=7.7, 7.6 Hz, 1H), 4.51 (s, 2H). LCMS-ESI failed to provide reliable data.
Reference: [1] Patent: US2011/150836, 2011, A1,
  • 14
  • [ 1191-15-7 ]
  • [ 28188-41-2 ]
  • [ 82072-23-9 ]
Reference: [1] Patent: US6489487, 2002, B1,
  • 15
  • [ 28188-41-2 ]
  • [ 34231-22-6 ]
Reference: [1] Journal of Medicinal Chemistry, 2014, vol. 57, # 19, p. 8140 - 8151
  • 16
  • [ 28188-41-2 ]
  • [ 57213-48-6 ]
Reference: [1] Patent: WO2004/103984, 2004, A1,
  • 17
  • [ 28188-41-2 ]
  • [ 220364-34-1 ]
Reference: [1] Journal of Medicinal Chemistry, 2014, vol. 57, # 19, p. 8140 - 8151
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 28188-41-2 ]

Aryls

Chemical Structure| 114772-54-2

[ 114772-54-2 ]

4'-(Bromomethyl)-[1,1'-biphenyl]-2-carbonitrile

Similarity: 0.91

Chemical Structure| 72054-56-9

[ 72054-56-9 ]

4-(2-Bromoethyl)benzonitrile

Similarity: 0.82

Chemical Structure| 89892-39-7

[ 89892-39-7 ]

3-Bromo-4-(bromomethyl)benzonitrile

Similarity: 0.79

Chemical Structure| 52780-15-1

[ 52780-15-1 ]

3-Bromo-2-methylbenzonitrile

Similarity: 0.78

Chemical Structure| 73217-11-5

[ 73217-11-5 ]

2-(2-(Bromomethyl)phenyl)acetonitrile

Similarity: 0.77

Bromides

Chemical Structure| 114772-54-2

[ 114772-54-2 ]

4'-(Bromomethyl)-[1,1'-biphenyl]-2-carbonitrile

Similarity: 0.91

Chemical Structure| 72054-56-9

[ 72054-56-9 ]

4-(2-Bromoethyl)benzonitrile

Similarity: 0.82

Chemical Structure| 89892-39-7

[ 89892-39-7 ]

3-Bromo-4-(bromomethyl)benzonitrile

Similarity: 0.79

Chemical Structure| 52780-15-1

[ 52780-15-1 ]

3-Bromo-2-methylbenzonitrile

Similarity: 0.78

Chemical Structure| 73217-11-5

[ 73217-11-5 ]

2-(2-(Bromomethyl)phenyl)acetonitrile

Similarity: 0.77

Benzyl Bromides

Chemical Structure| 114772-54-2

[ 114772-54-2 ]

4'-(Bromomethyl)-[1,1'-biphenyl]-2-carbonitrile

Similarity: 0.91

Chemical Structure| 89892-39-7

[ 89892-39-7 ]

3-Bromo-4-(bromomethyl)benzonitrile

Similarity: 0.79

Chemical Structure| 73217-11-5

[ 73217-11-5 ]

2-(2-(Bromomethyl)phenyl)acetonitrile

Similarity: 0.77

Chemical Structure| 156001-53-5

[ 156001-53-5 ]

5-Bromo-2-(bromomethyl)benzonitrile

Similarity: 0.77

Chemical Structure| 209911-63-7

[ 209911-63-7 ]

4'-(Dibromomethyl)-[1,1'-biphenyl]-2-carbonitrile

Similarity: 0.77

Nitriles

Chemical Structure| 114772-54-2

[ 114772-54-2 ]

4'-(Bromomethyl)-[1,1'-biphenyl]-2-carbonitrile

Similarity: 0.91

Chemical Structure| 72054-56-9

[ 72054-56-9 ]

4-(2-Bromoethyl)benzonitrile

Similarity: 0.82

Chemical Structure| 89892-39-7

[ 89892-39-7 ]

3-Bromo-4-(bromomethyl)benzonitrile

Similarity: 0.79

Chemical Structure| 52780-15-1

[ 52780-15-1 ]

3-Bromo-2-methylbenzonitrile

Similarity: 0.78

Chemical Structure| 73217-11-5

[ 73217-11-5 ]

2-(2-(Bromomethyl)phenyl)acetonitrile

Similarity: 0.77